Axitan appoints Guillermo Zavala as VP Sales & Marketing

Axitan has developed a ground breaking approach for addressing economically important bacteria that impact the livestock industry

Axitan, a leading biotech company focused on the development of endolysin enzyme products to replace antibiotics in animal feed, is pleased to announce the appointment of Good Grain Network

Feed & Additive talks to the founder and Chief Innovation Officer at Axitan, Dr Kane Miller.

Axitan expands fermentation team with appointment of Sam Romes

WATTPoultry discuss Axitan’s 2024 progress with the senior management team

Axitan & Qualitech announce strategic partnership to develop & distribute new endolysin products for poultry, swine & ruminant industries

White Paper 2: Challenge trial results of FORC3^® against Clostridium perfringens in broilers

White Paper 3: Performance results in field trials

NMAN^® - The supplement that newly hatched chicks prefer

FORC3^® - Three industry challenges - one solution

Axitan - The next generation of antibiotic free production

White Paper 1: In Vitro Efficacy of FORC3^® against Clostridium perfringens

Feed & Additive interview with Axitan CEO

Axitan appoints Ex Novus MD as its VP Sales & Marketing

Axitan appoints seasoned industry leader as CEO

Feed Strategy Magazine podcast with Axitan CEO 

Axitan CEO forms part of UK delegation invited to Thai Biotech Symposium on Feed Supplements for Aquaculture

Axitan expands its UK & US operations with key hires in each region

Axitan’s intellectual property gains steam